The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126033181 12603318 1 I 20160707 20160718 20160728 20160728 EXP GB-MHRA-TPP9964479C403336YC1467912927896 GB-WATSON-2016-16274 WATSON 47.00 YR F Y 116.00000 KG 20160728 CN GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126033181 12603318 1 PS CITALOPRAM CITALOPRAM HYDROBROMIDE 1 Buccal 10 MG, UNKNOWN U UNCONFIRMED 77034 10 MG UNK
126033181 12603318 2 SS CITALOPRAM CITALOPRAM HYDROBROMIDE 1 Buccal 20 MG, UNKNOWN U UNCONFIRMED 77034 20 MG UNK
126033181 12603318 3 C AMLODIPINE AMLODIPINE BESYLATE 1 Oral 1 DF, DAILY 2715 DF U 0 1 DF QD
126033181 12603318 4 C CLARITHROMYCIN. CLARITHROMYCIN 1 Oral 1 DF, BID 72 DF Y 0 1 DF BID
126033181 12603318 5 C CODEINE PHOSPHATE CODEINE PHOSPHATE 1 Oral 1 DF, QID (WHEN NEEDED) 248 DF Y 0 1 DF
126033181 12603318 6 C DOCUSATE SODIUM. DOCUSATE SODIUM 1 Oral 1 DF, QID (IF NEEDED) 248 DF Y 0 1 DF
126033181 12603318 7 C DOXAZOSIN DOXAZOSINDOXAZOSIN MESYLATE 1 Oral 1 DF, DAILY 1297 DF U 0 1 DF QD
126033181 12603318 8 C INDAPAMIDE. INDAPAMIDE 1 Oral 1 DF, QAM (EVERY MORNING) 1543 DF U 0 1 DF QD
126033181 12603318 9 C RAMIPRIL. RAMIPRIL 1 Oral 1 DF, DAILY 2338 DF U 0 1 DF QD
126033181 12603318 10 C REVAXIS DIPHTHERIA AND TETANUS TOXOIDS AND POLIOVIRUS VACCINE ANTIGENS 1 Unknown UNK, UNKNOWN Y 0
126033181 12603318 11 C SENNA /00142201/ SENNA LEAF 1 Oral UNK UNK, PRN (ONE OR TWO TO BE TAKEN AT NIGHT FOR C...) Y 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126033181 12603318 1 Product used for unknown indication
126033181 12603318 3 Product used for unknown indication
126033181 12603318 4 Product used for unknown indication
126033181 12603318 5 Product used for unknown indication
126033181 12603318 6 Product used for unknown indication
126033181 12603318 7 Product used for unknown indication
126033181 12603318 8 Product used for unknown indication
126033181 12603318 9 Product used for unknown indication
126033181 12603318 10 Product used for unknown indication
126033181 12603318 11 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126033181 12603318 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126033181 12603318 Agitation
126033181 12603318 Feeling hot
126033181 12603318 Hyperhidrosis
126033181 12603318 Mood altered
126033181 12603318 Serotonin syndrome
126033181 12603318 Tremor

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126033181 12603318 3 20090130 0
126033181 12603318 4 20160601 20160608 0
126033181 12603318 5 20160506 20160603 0
126033181 12603318 6 20160506 20160531 0
126033181 12603318 7 20121218 0
126033181 12603318 8 20120416 0
126033181 12603318 9 20100211 0
126033181 12603318 10 20160428 20160429 0
126033181 12603318 11 20160506 20160605 0